B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma.

MLA

Tai, Yu-Tzu, and Kenneth C. Anderson. “B Cell Maturation Antigen (BCMA)-Based Immunotherapy for Multiple Myeloma.” Expert Opinion on Biological Therapy, vol. 19, no. 11, Nov. 2019, pp. 1143–56. EBSCOhost, https://doi.org/10.1080/14712598.2019.1641196.

APA

Tai, Y.-T., & Anderson, K. C. (2019). B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma. Expert Opinion on Biological Therapy, 19(11), 1143–1156. https://doi.org/10.1080/14712598.2019.1641196

Chicago

Tai, Yu-Tzu, and Kenneth C Anderson. 2019. “B Cell Maturation Antigen (BCMA)-Based Immunotherapy for Multiple Myeloma.” Expert Opinion on Biological Therapy 19 (11): 1143–56. doi:10.1080/14712598.2019.1641196.